American Heart Association Ventures invests in MDisrupt
Lisa SuenenManaging Partner of American Heart Association Ventures and longtime healthcare veteran, joins MDisrupt Board MDisrupt's Marketplace will be available to thousands of American Heart Association professional members American Heart Association and MDisrupt collaborate to expand AI-powered health expert marketplace
Austin, Texas, October 15, 2024 /PRNewswire/ — MDisrupt, the leading expert marketplace for the health tech and life sciences industry, today announced that it has achieved milestone-based recognition. 1 million dollars Investment from American Heart Association Ventures. A newly created venture arm that leads and coordinates the association's venture capital investments. Additionally, the American Heart Association has entered into a service agreement with MDisrupt.
This investment will support the expansion of MDisrupt's recently launched artificial intelligence (AI)-powered medical expert marketplace. This marketplace is designed for small businesses to large enterprises that want quick and reliable access to vetted clinical, commercial, and scientific experts to advise them on designing, building, commercializing, and scaling their healthcare products and services. designed to meet the growing demand for
Additionally, MDisrupt will add new features to its marketplace platform through strategic collaborations with associations to meet the needs of its members and provide new ways to participate in the medical technology, medical services, medical devices, and life sciences sectors. . This collaboration will enable members to advance the Society's mission of disseminating high-quality, evidence-based scientific expertise across the healthcare ecosystem.
“Healthcare professionals are the catalysts behind scalable, science-based innovation. This strategic investment from American Heart Association Ventures is a partnership with leading clinicians and scientists specializing in cardiovascular and brain health. “Accelerates our mission to provide healthcare and life sciences companies with unparalleled access to their customers.” Ruby GadelloveFounder and CEO of MDisrupt. “Working with the association creates a unique opportunity for our thousands of members to engage with industry, apply their expertise to new roles and shape the future of medical technology.”
Healthcare Industry Veteran Lisa SuenenManaging Partner of American Heart Association Ventures also joined MDisrupt's Board of Directors, bringing decades of leadership experience and a proven track record in health innovation to support MDisrupt's continued growth.
“We are excited about this relationship, which will bring even more value to American Heart Association members and advance scientifically validated, evidence-based solutions that are essential to the healthcare industry. “It allows us to expand on the great knowledge of our members,” Suenen said. “We are excited about the opportunity to make this strategic investment in MDisrupt and support our members and the healthcare and life sciences market by matching needs and expertise in a way that benefits everyone. We are excited. Through this collaboration, MDisrupt will help provide valuable services to our association members. ”This is a unique opportunity to shape the next generation of healthcare solutions. ”
American Heart Association Ventures is the investment platform that leads and coordinates the association's venture capital program, funding programs that reliably translate high-quality, evidence-based science, research, and clinical know-how into practical applications. We build on our overall mission by delivering. Delivering meaningful, equitable and sustainable positive impact for patients and health systems.
Suenen added, “Our collaboration with MDisrupt will help us achieve our mission of being a relentless force for the world to live longer, healthier lives. The American Heart Association Building on more than 100 years of trusted leadership in brain health and brain health, we are focused on: We are committed to driving breakthrough advances and helping advance proven solutions that advance health and hope for everyone, everywhere. ”
Healthcare Professionals – Key Elements of Success for New Healthcare Products and Services
Innovation abounds in health technology, technology-enabled services, medical devices, and life sciences, but the path to success is difficult. for example, US75 percent of medical device startups fail and 98 percent of digital health startups don't survive. The landscape of connected devices and apps is similarly challenging, with an astonishing 350,000 health apps available and over 90,000 apps released in 2020 alone, yet around 53 percent are released within 30 days. has been uninstalled. Early-stage healthcare companies often stumble due to a lack of clinical, regulatory, and commercialization expertise. They also face significant postmarket obstacles, such as recalls, reimbursement issues, or poor market performance.
“Too many promising companies struggle not because of a lack of innovation, but because they don't have access to highly specialized medical expertise when they need it most: avoiding complex regulations; Due to the nuances of evidence generation, commercialization, or collaboration with payers and health systems, the healthcare-specific guidance we provide through MDisrupt is critical and differs from common expert platforms. Differently, we focus on all aspects of healthcare, providing vetted experts at the right time to accelerate your company's time to market, so you can move faster and more responsibly. ” said Gadellove.
The MDisrupt marketplace currently includes Blue Cross Blue Shield, Walgreens, CVS, willis towers watsonUS FDA, Optum, Humana, Kaiser, Cleveland Clinic, etc.
MDisrupt's AI-powered health expert marketplace connects health tech and life sciences companies, venture and private equity funds with vetted experts with highly specialized and nuanced skills to address healthcare-specific challenges. I will connect it with. The platform's precise matching ensures that companies find the experts they need, whether they have clinical, commercial, regulatory or reimbursement expertise. Companies can engage these professionals in a variety of ways, from hourly consulting and advisory boards to partial, part-time, or full-time roles, providing flexibility to suit any stage of growth. and customized expertise.
MDisrupt is led by Gadelrab, an experienced health tech executive who has successfully commercialized healthcare and life sciences, served on the executive team of 23andMe, and advised many leading companies in the biotech and genetics sectors. was founded by. Raised by MDisrupt $6.6 million Previous versions including the latest 3 million dollars With seed funding. Notable investors include The Venture Collective, Capita3, The Good Science Fund, Zane Venture Fund, Growth Factory, susan solinski, Matthew Holtand other strategic investors and industry leaders in the healthcare and technology sectors.
About MDisrupt
MDisrupt is the leading expert marketplace for the medical technology and life sciences industry, connecting companies with more than 2,500 leading experts, including clinicians, health system executives, and payers. The company's AI-powered platform streamlines access to critical expertise and enables rapid product development and validation. By bringing together the best talent in healthcare, MDisrupt ensures that medical innovations are built on a foundation of clinical rigor and ready to accelerate market success. For more information, please visit www.mdisrupt.com and follow us on LinkedIn.
Media contact:
Rob Mazzini
MDisrupt PR
(646) 599-3502
(email protected)
Logo – https://mma.prnewswire.com/media/2531330/MDisrupt_Logo.jpg
